Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial (Q86706145)
Jump to navigation
Jump to search
scientific article published on 04 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial |
scientific article published on 04 November 2014 |
Statements
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial (English)
Uma Kher
Sukrut Shah
Christopher P Cannon
Michael Davidson
Antonio M Gotto
Tanya B Ashraf
Christine McCrary Sisk
Hayes Dansky
Yale Mitchel
Philip Barter
DEFINE Investigators
4 November 2014